AI co-pilot for robot surgery tested in rectal cancer patients

NCT ID NCT05652361

Recruiting now Knowledge-focused Sponsor: Technische Universität Dresden Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This first-in-human study tests a machine learning system that provides real-time guidance during robot-assisted rectal cancer surgery. The system aims to help surgeons by predicting the correct surgical plane. Twelve patients with rectal cancer will be enrolled to see if the technology is feasible and safe. The study does not yet aim to prove that it improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Machine learning-based surgical guidance software
What this could lead to: If successful, this could improve precision in rectal cancer surgery, potentially leading to better outcomes and fewer complications.
What could go wrong: This is a very early, small study (12 people) focused on feasibility, not effectiveness. The system may not work as expected or may not improve surgery outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTUM CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTUM CANCER

Contacts and locations

Locations

Department of Visceral, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus Technische Universität Dresden
RECRUITING

Dresden, Saxony, 01307, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.